Cancer Prevention and Early Detection Among the Homeless Population: The Health Navigator Model

NCT05406687 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 654

Last updated 2024-01-08

No results posted yet for this study

Summary

Prevention and early detection are key for the decrease of cancer-related mortality. However, socially deprived population groups don't have the privilege of unburdened access to the healthcare system. The EU-funded CANCERLESS project aims to develop an evidence-based, patient-centred innovation that reinforces patients through health education and social support and fosters timely access to primary and secondary prevention services. Based on the combination of the tested Patient Navigator Model and the Patient Empowerment Model, CANCERLESS will develop the Health Navigator Model for Europe, addressed to the underserved population.

Conditions

Interventions

OTHER

Health Navigator Model

The Health Navigator Model will be a longitudinal, person-centered and community-based intervention focused on addressing both primary and secondary cancer prevention, as well as reducing wider barriers to healthcare. Health Navigators (HNs) will be professionals who have a background in social care and an understanding of the local user population, and will be embedded in settings familiar and accessible to people experiencing homelessness. The primary aspects of the HN role will be to identify the health needs and barriers of users, promote cancer awareness and education, facilitate timely access to healthcare services and cancer screening, provide practical assistance, delivered through regular in-person meetings, and utilize wider stakeholders, including healthcare professionals, to deliver the intervention. A comprehensive training package will be delivered to the HNs, covering population specific knowledge, interpersonal skills, cancer education and local resources.

Sponsors & Collaborators

  • University of Valencia

    collaborator OTHER
  • Senior Europa Sociedad Limitada

    collaborator UNKNOWN
  • Ministry of Social Policies and Family, Spain

    collaborator UNKNOWN
  • Servicio Madrileño de Salud, Madrid, Spain

    collaborator OTHER
  • International Foundation for Integrated Care

    collaborator UNKNOWN
  • Programs of Development, Social Support and Medical Cooperation Association

    collaborator UNKNOWN
  • European Federation of National Organisations working with the Homeless

    collaborator UNKNOWN
  • Prolepsis Institute for Preventive, Environmental and Occupational Medicine

    collaborator OTHER
  • Anglia Ruskin University

    collaborator OTHER
  • Universitat Politècnica de València

    collaborator OTHER
  • Medical University of Vienna

    lead OTHER

Principal Investigators

  • Igor Grabovac, MD, PhD · Medical University of Vienna

Study Design

Allocation
NA
Purpose
PREVENTION
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-06-08
Primary Completion
2023-12-29
Completion
2023-12-29

Countries

  • Austria
  • Greece
  • Spain
  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05406687 on ClinicalTrials.gov